期刊文献+

利用CT观察肝癌内碘化油的沉积指导再行血管介入治疗时机的研究 被引量:6

The study of using CT to observe iodized oil keeping in the hepatocarcinoma lesion to guide the opportunity of vascular intervention treatment again
下载PDF
导出
摘要 目的 :探讨利用CT观察肝癌内碘化油沉积情况 ,来指导再行TACE治疗时机。方法 :对临床诊断证实的 12 0例原发性肝癌患者 ,采用Seldinger技术经皮行选择性肝动脉插管TACE治疗术 ,术后 4周再行CT平扫 ,观察肝癌区内碘化油沉积情况。结果 :12 0例患者TACE治疗间隔时间最短为 1个月 ,最长为 6个月 ;治疗后肿瘤灶缩小约 5 0 %者 32例 (2 6 .7% ) ,肿瘤缩小约 30 %~ 4 0 %者 6 6例 (5 5 .0 % ) ,肿瘤无明显变化者 2 2例 (18.3% )。患者生存率 2年者 86例 (71 7% )、3年者 18例 (15 % )、4年者 12例 (10 % )、5年者 4例 (3.3% )。结论 :利用CT观察肝癌内碘化油沉积情况 ,指导再行TACE治疗时机 。 Objective:Exploration using CT to observe iodized oil keeping in the hepatocarcinoma lesion to guide the opportunity of vascular intervention treatment again.Methods:Using Seldinger technique, performing transcatheter arterial chemotherapy and transcatheter arterial iodized oil embolization to treat 120 cases hepatocarcinoma who confirmed by clinical diagnosis. Four weeks after intervention treatment, performing common CT scan in order to observe the situation that iodized oil be kept in the hepatocarcinoma lesion.Results:The interval of vascular intervention treatment is 1-6 months.The subsist rate of the patients:two years is 86 cases(71.7%);three years is 18 cases(15%);four years is 12 cases(10%);five years is 4 cases(3.3%).Conclusion:It is a simple?available and ideal method that using CT to observe iodized oil keeping in the hepatocarcinoma lesion to guide the opportunity of vascular intervention treatment again.
出处 《医学影像学杂志》 2002年第4期303-305,共3页 Journal of Medical Imaging
关键词 CT 肝癌 碘化油 沉积 血管介入治疗 治疗时机 肝动脉化疗栓塞术 Hepatocarcinoma Transcatheter arterial chemoembolization Tomography,X ray computed
  • 相关文献

参考文献7

二级参考文献13

共引文献127

同被引文献28

  • 1张刚,周翔平,官泳松.原发性肝癌TACE术后碘化油沉积与其血供相关性研究[J].医学影像学杂志,2004,14(9):718-721. 被引量:11
  • 2韩国宏,郭庆林,郭宇良,黄高升.碘油肝动脉栓塞后在肝癌内的选择性聚积、持续存留和逐渐消失(血管造影、CT和病理对照研究)[J].实用放射学杂志,1995,11(11):648-652. 被引量:17
  • 3高思佳,王长龙,何芳显,韩铭钧,姜洪刚,关超,姜宗源.肝癌栓塞后碘油沉积形态与疗效关系的研究[J].中国医科大学学报,1996,25(2):177-180. 被引量:9
  • 4Liado L,Virgili J,Figuems J,et al.A Pmgnositic index of the survival of patients with unmsectable hepatocellular carcinoma after transcatheter arterial chemoembolization[J].Cancer,2000;88(1):50-53.
  • 5中华医学会中华放射学杂志编委会介入放射学组.肝癌介入治疗规范化条例(草案)[J].中华放射学杂志,2001,12:887-891.
  • 6Park C,Choi SI,Kim H,et al.Distribution of lipiodol in the hepatocellular carcinoma[J].Liver,1990,10:72-78.
  • 7Maki S,Konno T,Maeda H.Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium[J].Cancer,1985,56:751-757.
  • 8巫协宁.临床肝胆系病学[M].上海:上海科学技术文献出版社,2002.283.
  • 9Chuang Vp, Wallace S. Hepatic artery embolization in the treatment of hepatic neoplasms[J].Radiology,1981,140:51.
  • 10Kanematsu T, Furuta T, Takenaka K, et al. A 5-year experience of lipidolization: selective regional chemotherapy for 200 patients with hepatocellular[J]. Hepatology,1989,10:98.

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部